Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 192

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Neuroprotection in stroke: the importance of collaboration and reproducibility

Neuhaus, Ain A, Couch, Yvonne, Hadley, Gina, Buchan, Alastair M·2017·Brain
DOI 10.1093/brain/awx126
Open this paper in CoChat — free account

Abstract

Acute ischaemic stroke accounts for 6.5 million deaths per year, and by 2030 will result in the annual loss of over 200 million disability-adjusted life years globally. There have been considerable recent advances in the gold standard of acute ischaemic stroke treatment, some aspects of which-aspirin to prevent recurrence, and treating patients in specialized stroke wards-are widely applicable. Recanalization of the occluded artery through thrombolysis and/or endovascular thrombectomy is restricted to only a small proportion of patients, due to contra-indications and the costs associated with establishing the infrastructure to deliver these treatments. The use of neuroprotective agents in stroke has been a notable failure of translation from medical research into clinical practice. Yet, with the advent of endovascular thrombectomy and the ability to investigate patients in much greater detail through advanced imaging modalities, neuroprotective agents can and should be re-examined as adjunct therapies to recanalization. In parallel, this requires appropriate planning on behalf of the preclinical stroke research community: there is a need to reinvestigate these therapies in a more collaborative manner, to enhance reproducibility through reduced attrition, improved reporting, and adopting an approach to target validation that more closely mimics clinical trials. This review will describe some of the novel strategies being used in stroke research, and focus on a few key examples of neuroprotective agents that are showing newfound promise in preclinical models of stroke therapy. Our primary aim is to give an overview of some of the challenges faced by preclinical stroke research, and suggest potential ways to improve translational success.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awx126

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 105

  1. Adams, 1993, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, 24, 35, 10.1161/01.STR.24.1.35 · DOI · Paper page
  2. Adams, 2008, Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II), Stroke, 39, 87, 10.1161/STROKEAHA.106.476648 · DOI · Paper page
  3. Alvarez-Sabin, 2013, Factors influencing haemorrhagic transformation in ischaemic stroke, Lancet Neurol, 12, 689, 10.1016/S1474-4422(13)70055-3 · DOI · Paper page
  4. Ames, 1968, Cerebral ischemia. II. The no-reflow phenomenon, Am J Pathol, 52, 437
  5. Aron, 2015, Prestroke living situation and depression contribute to initial stroke severity and stroke recovery, J Stroke Cerebrovasc Dis, 24, 492, 10.1016/j.jstrokecerebrovasdis.2014.09.024 · DOI
  6. Badhiwala, 2015, Endovascular thrombectomy for acute ischemic stroke: a meta-analysis, JAMA, 314, 1832, 10.1001/jama.2015.13767 · DOI · Paper page
  7. Balami, 2013, The exact science of stroke thrombolysis and the quiet art of patient selection, Brain, 136, 3528, 10.1093/brain/awt201 · DOI
  8. Balami, 2015, A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke, Int J Stroke, 10, 1168, 10.1111/ijs.12618 · doi:10.1111/ijs.12618
  9. Bardutzky, 2005, Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging, Stroke, 36, 2000, 10.1161/01.STR.0000177486.85508.4d · DOI
  10. Barreto, 2011, Astrocytes: targets for neuroprotection in stroke, Cent Nerv Syst Agents Med Chem, 11, 164, 10.2174/187152411796011303 · DOI · Paper page
  11. Begley, 2015, Robust research: institutions must do their part for reproducibility, Nature, 525, 25, 10.1038/525025a · DOI
  12. Black, 2015, Ischemic stroke: from next generation sequencing and GWAS to community genomics?, OMICS, 19, 451, 10.1089/omi.2015.0083 · DOI
  13. Brambilla, 2013, The effect of stroke on immune function, Mol Cell Neurosci, 53, 26, 10.1016/j.mcn.2012.08.011 · DOI
  14. Broderick, 2013, Endovascular therapy after intravenous t-PA versus t-PA alone for stroke, N Engl J Med, 368, 893, 10.1056/NEJMoa1214300 · DOI · Paper page
  15. Buchan, 1991, The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats, J Neurosci, 11, 1049, 10.1523/JNEUROSCI.11-04-01049.1991 · DOI · Paper page
  16. Buchhold, 2007, Environmental enrichment improves functional and neuropathological indices following stroke in young and aged rats, Restor Neurol Neurosci, 25, 467
  17. Buck, 2008, Early neutrophilia is associated with volume of ischemic tissue in acute stroke, Stroke, 39, 355, 10.1161/STROKEAHA.107.490128 · DOI · Paper page
  18. Busch, 1997, Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat, Brain Res, 778, 16, 10.1016/S0006-8993(97)01008-1 · DOI
  19. Campbell, 2015, Endovascular therapy for ischemic stroke, N Engl J Med, 372, 1009, 10.1056/NEJMoa1414792 · DOI · Paper page
  20. Chamorro, 2014, Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial, Lancet Neurol, 13, 453, 10.1016/S1474-4422(14)70054-7 · DOI · Paper page
  21. Chamorro, 2016, Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation, Lancet Neurol, 15, 869, 10.1016/S1474-4422(16)00114-9 · DOI · Paper page
  22. Chen, 2000, Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial, On behalf of the CAST and IST collaborative groups. Stroke, 31, 1240
  23. Chopp, 2009, Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies, Stroke, 40, S143, 10.1161/STROKEAHA.108.533141 · DOI
  24. Ciccone, 2013, Endovascular treatment for acute ischemic stroke, N Engl J Med, 368, 904, 10.1056/NEJMoa1213701 · DOI · Paper page
  25. Cook, 2012, Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain, Nature, 483, 213, 10.1038/nature10841 · DOI · Paper page
  26. Cramer, 2013, Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke, Stroke, 44, 1337, 10.1161/STROKEAHA.111.674366 · DOI
  27. David, 2015, Neuroinflammation: new insights into beneficial and detrimental functions, 10.1002/9781118732748 · doi:10.1002/9781118732748
  28. de Bilbao, 2009, In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice, J Neurochem, 110, 12, 10.1111/j.1471-4159.2009.06098.x · DOI
  29. del Zoppo, 2003, Cerebral microvessel responses to focal ischemia, J Cereb Blood Flow Metab, 23, 879, 10.1097/01.WCB.0000078322.96027.78 · DOI · Paper page
  30. del Zoppo, 1991, Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons, Stroke, 22, 1276, 10.1161/01.STR.22.10.1276 · DOI · Paper page
  31. Dickens, 2015, NMR-based metabolomics separates the distinct stages of disease in a chronic relapsing model of multiple sclerosis, J Neuroimmune Pharmacol, 10, 435, 10.1007/s11481-015-9622-0 · DOI
  32. Dirnagl, 2014, Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes, Stroke, 45, 1510, 10.1161/STROKEAHA.113.004075 · DOI · Paper page
  33. Dirnagl, 2013, A concerted appeal for international cooperation in preclinical stroke research, Stroke, 44, 1754, 10.1161/STROKEAHA.113.000734 · DOI
  34. Dirnagl, 2010, Fighting publication bias: introducing the negative results section, J Cereb Blood Flow Metab, 30, 1263, 10.1038/jcbfm.2010.51 · DOI
  35. Dreier, 2011, The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease, Nat Med, 17, 439, 10.1038/nm.2333 · DOI · Paper page
  36. Ebinger, 2014, Ambulance-based thrombolysis in acute ischemic stroke–reply, JAMA, 312, 961, 10.1001/jama.2014.8378 · doi:10.1001/jama.2014.8378
  37. Eilaghi, 2013, Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke, Radiology, 269, 240, 10.1148/radiol.13122327 · doi:10.1148/radiol.13122327
  38. Erdo, 2003, Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke, J Cereb Blood Flow Metab, 23, 780, 10.1097/01.WCB.0000071886.63724.FB · DOI · Paper page
  39. Feigin, 2015, Update on the global burden of ischemic and hemorrhagic stroke in 1990–2013: the GBD 2013 study, Neuroepidemiology, 45, 161, 10.1159/000441085 · DOI · Paper page
  40. Feng, 2011, Edaravone for acute ischaemic stroke, Cochrane Database Syst Rev, 10.1002/14651858.CD007230.pub2 · DOI
  41. Fisher, 2009, Update of the stroke therapy academic industry roundtable preclinical recommendations, Stroke, 40, 2244, 10.1161/STROKEAHA.108.541128 · DOI · Paper page
  42. Futrell, 1991, Embolic stroke in aged rats, Stroke, 22, 1582, 10.1161/01.STR.22.12.1582 · DOI
  43. Ganesh, 2016, Infarct in a new territory after treatment administration in the ESCAPE randomized controlled trial (Endovascular treatment for small core and anterior circulation proximal occlusion with emphasis on minimizing CT to recanalization times), Stroke, 47, 2993, 10.1161/STROKEAHA.116.014852 · doi:10.1161/strokeaha.116.014852
  44. Gerczuk, 2012, An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials, J Am Coll Cardiol, 59, 969, 10.1016/j.jacc.2011.07.054 · DOI · Paper page
  45. Goyal, 2016, Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials, Lancet, 387, 1723, 10.1016/S0140-6736(16)00163-X · DOI · Paper page
  46. Gregersen, 2000, Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice, J Cereb Blood Flow Metab, 20, 53, 10.1097/00004647-200001000-00009 · DOI · Paper page
  47. Hachinski, 2010, Stroke: working toward a prioritized world agenda, Stroke, 41, 1084, 10.1161/STROKEAHA.110.586156 · DOI
  48. Harston, 2015, Identifying the ischaemic penumbra using pH-weighted magnetic resonance imaging, Brain, 138, 36, 10.1093/brain/awu374 · DOI · Paper page
  49. Hill, 2012, Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet Neurol, 11, 942, 10.1016/S1474-4422(12)70225-9 · DOI · Paper page
  50. Hossmann, 1997, Reperfusion of the brain after global ischemia: hemodynamic disturbances, Shock, 8, 95, 10.1097/00024382-199708000-00004 · DOI
  51. Howells, 2010, Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia, J Cereb Blood Flow Metab, 30, 1412, 10.1038/jcbfm.2010.66 · DOI · Paper page
  52. Hoyte, 2004, The rise and fall of NMDA antagonists for ischemic stroke, Curr Mol Med, 4, 131, 10.2174/1566524043479248 · DOI · Paper page
  53. Hua, 2015, TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice, J Cereb Blood Flow Metab, 35, 536, 10.1038/jcbfm.2014.240 · DOI · Paper page
  54. Ito, 2011, The identification of novel protein, brain-derived integrating factor-1 (BDIF1), which interacts with astrocytic gap junctional protein, Neurosci Res, 70, 330, 10.1016/j.neures.2011.03.008 · DOI
  55. Jin, 2010, Inflammatory mechanisms in ischemic stroke: role of inflammatory cells, J Leukoc Biol, 87, 779, 10.1189/jlb.1109766 · DOI · Paper page
  56. Jove, 2015, Metabolomics predicts stroke recurrence after transient ischemic attack, Neurology, 84, 36, 10.1212/WNL.0000000000001093 · DOI
  57. Kaito, 2013, Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients, PLoS One, 8, e69409, 10.1371/journal.pone.0069409 · DOI
  58. Kalladka, 2016, Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study, Lancet, 388, 787, 10.1016/S0140-6736(16)30513-X · DOI · Paper page
  59. Khatri, 2005, Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I, Stroke, 36, 2400, 10.1161/01.STR.0000185698.45720.58 · DOI · Paper page
  60. Kim, 2014, Role of spleen-derived monocytes/macrophages in acute ischemic brain injury, J Cereb Blood Flow Metab, 34, 1411, 10.1038/jcbfm.2014.101 · DOI · Paper page
  61. Kunze, 2014, Strain differences in fatigue and depression after experimental stroke, Transl Stroke Res, 5, 604, 10.1007/s12975-014-0350-1 · DOI
  62. Lambertsen, 2009, Microglia protect neurons against ischemia by synthesis of tumor necrosis factor, J Neurosci, 29, 1319, 10.1523/JNEUROSCI.5505-08.2009 · DOI · Paper page
  63. Lang, 2008, Pathways to ischemic neuronal cell death: are sex differences relevant?, J Transl Med, 6, 33, 10.1186/1479-5876-6-33 · DOI · Paper page
  64. Laskowitz, 2009, Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the biomarker rapid assessment in ischemic injury (BRAIN) study, Stroke, 40, 77, 10.1161/STROKEAHA.108.516377 · DOI · Paper page
  65. Lin, 1998, Gap-junction-mediated propagation and amplification of cell injury, Nat Neurosci, 1, 494, 10.1038/2210 · DOI · Paper page
  66. Llovera, 2015, Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia, Sci Transl Med, 7, 299ra121, 10.1126/scitranslmed.aaa9853 · DOI · Paper page
  67. Macrae, 1993, Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences, J Cereb Blood Flow Metab, 13, 276, 10.1038/jcbfm.1993.34 · DOI · Paper page
  68. Manzanero, 2013, Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury, Neurochem Int, 62, 712, 10.1016/j.neuint.2012.11.009 · DOI · Paper page
  69. Mayzel-Oreg, 2004, Microsphere-induced embolic stroke: an MRI study, Magn Reson Med, 51, 1232, 10.1002/mrm.20100 · DOI
  70. McColl, 2010, Modeling risk factors and confounding effects in stroke, Rodent Models Stroke, 47, 93, 10.1007/978-1-60761-750-1_9 · DOI · Paper page
  71. Meretoja, 2013, Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months, Neurology, 81, 1071, 10.1212/WNL.0b013e3182a4a4d2 · doi:10.1212/wnl.0b013e3182a4a4d2
  72. Mozaffarian, 2015, Heart disease and stroke statistics–2015 update: a report from the American Heart Association, Circulation, 131, e29, 10.1161/CIR.0000000000000152 · DOI · Paper page
  73. Nakase, 2004, Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes, Am J Pathol, 164, 2067, 10.1016/S0002-9440(10)63765-0 · DOI · Paper page
  74. Neuhaus, 2014, Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke, JAMA Neurol, 71, 634, 10.1001/jamaneurol.2013.6299 · DOI
  75. Ning, 2010, Proteomic protease substrate profiling of tPA treatment in acute ischemic stroke patients: a step toward individualizing thrombolytic therapy at the bedside, Transl Stroke Res, 1, 268, 10.1007/s12975-010-0047-z · DOI
  76. O’Keefe, 2014, Social isolation after stroke leads to depressive-like behavior and decreased BDNF levels in mice, Behav Brain Res, 260, 162, 10.1016/j.bbr.2013.10.047 · DOI
  77. Okada, 1994, Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion, Stroke, 25, 1847, 10.1161/01.STR.25.9.1847 · DOI · Paper page
  78. Orset, 2007, Mouse model of in situ thromboembolic stroke and reperfusion, Stroke, 38, 2771, 10.1161/STROKEAHA.107.487520 · DOI · Paper page
  79. Ostergaard, 2013, The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model, J Cereb Blood Flow Metab, 33, 635, 10.1038/jcbfm.2013.18 · DOI
  80. Parada, 2013, The microglial alpha7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2, Antioxid Redox Signal, 19, 1135, 10.1089/ars.2012.4671 · DOI · Paper page
  81. Patel, 2013, Microglia and ischemic stroke: a double-edged sword, Int J Physiol Pathophysiol Pharmacol, 5, 73
  82. Pei, 2014, DAPK1-p53 interaction converges necrotic and apoptotic pathways of ischemic neuronal death, J Neurosci, 34, 6546, 10.1523/JNEUROSCI.5119-13.2014 · DOI
  83. Rha, 2007, The impact of recanalization on ischemic stroke outcome: a meta-analysis, Stroke, 38, 967, 10.1161/01.STR.0000258112.14918.24 · DOI · Paper page
  84. Riedel, 2011, The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length, Stroke, 42, 1775, 10.1161/STROKEAHA.110.609693 · DOI · Paper page
  85. Rozeman, 2016, Evolution of intra-arterial therapy for acute ischemic stroke in The Netherlands: MR CLEAN pretrial experience, J Stroke Cerebrovasc Dis, 25, 115, 10.1016/j.jstrokecerebrovasdis.2015.09.002 · doi:10.1016/j.jstrokecerebrovasdis.2015.09.002
  86. Saver, 2015, Prehospital use of magnesium sulfate as neuroprotection in acute stroke, N Engl J Med, 372, 528, 10.1056/NEJMoa1408827 · DOI · Paper page
  87. Schwab, 1998, Early hemicraniectomy in patients with complete middle cerebral artery infarction, Stroke, 29, 1888, 10.1161/01.STR.29.9.1888 · DOI · Paper page
  88. Sena, 2007, How can we improve the pre-clinical development of drugs for stroke?, Trends Neurosci, 30, 433, 10.1016/j.tins.2007.06.009 · DOI · Paper page
  89. Shuaib, 2007, NXY-059 for the treatment of acute ischemic stroke, N Engl J Med, 357, 562, 10.1056/NEJMoa070240 · DOI · Paper page
  90. Soares, 2009, MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse!, Stroke, 40, S24, 10.1161/STROKEAHA.108.526814 · DOI
  91. Soares, 2010, Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients, Stroke, 41, e34, 10.1161/STROKEAHA.109.568766 · DOI · Paper page
  92. Stevens, 2008, Toll-like receptor 9: a new target of ischemic preconditioning in the brain, J Cereb Blood Flow Metab, 28, 1040, 10.1038/sj.jcbfm.9600606 · DOI · Paper page
  93. Stichel, 1998, The CNS lesion scar: new vistas on an old regeneration barrier, Cell Tissue Res, 294, 1, 10.1007/s004410051151 · DOI · Paper page
  94. Sutherland, 2013, Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat, J Cereb Blood Flow Metab, 33, e1, 10.1038/jcbfm.2013.148 · doi:10.1038/jcbfm.2013.148
  95. Sutherland, 2016, The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke, J Cereb Blood Flow Metab, 36, 363, 10.1177/0271678X15606722 · DOI
  96. The National Institute for Health and Care Excellence (NICE), 2016, Mechanical clot retrieval treating acute ischaemic stroke, NICE Interventional Procedure Guidance [IPG 548]
  97. Trialists’ Collaboration SU, 1997, How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials, Stroke, 28, 2139, 10.1161/01.STR.28.11.2139 · DOI · Paper page
  98. Wang, 2008, Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition, J Clin Neurosci, 15, 278, 10.1016/j.jocn.2007.02.004 · DOI
  99. Wardlaw, 2015, Thrombectomy for acute ischemic stroke, JAMA, 314, 1803, 10.1001/jama.2015.14674 · DOI
  100. Wardlaw, 2012, Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, Lancet, 379, 2364, 10.1016/S0140-6736(12)60738-7 · DOI · Paper page
  101. Wardlaw, 2014, Thrombolysis for acute ischaemic stroke, Cochrane Database Syst Rev, 7, CD000213
  102. Whiteley, 2016, Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis, Lancet Neurol, 15, 925, 10.1016/S1474-4422(16)30076-X · DOI · Paper page
  103. Yemisci, 2009, Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery, Nat Med, 15, 1031, 10.1038/nm.2022 · DOI · Paper page
  104. Zhang, 2010, Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke, J Cereb Blood Flow Metab, 30, 923, 10.1038/jcbfm.2010.10 · DOI · Paper page
  105. Zhang, 2012, Calcium antagonists for acute ischemic stroke, Cochrane Database Syst Rev, 5, CD001928

Cited by

See all 192

Metadata

Authors
Neuhaus, A. A., Couch, Y., Hadley, G., & Buchan, A. M.
Venue
Brain
Publisher
Oxford University Press (OUP)
Published
2017-06-20
Volume
140
Issue
8
Pages
2079-2092
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
DOI
10.1093/brain/awx126
OpenAlex
W2701376902
Cited by
192
References
21
FWCI
16.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroprotection in stroke: the importance of collaboration and reproducibility. https://app.cochat.ai/papers/10.1093/brain/awx126
The paper
Neuhaus, A. A., Couch, Y., Hadley, G., & Buchan, A. M. (2017). Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain. https://doi.org/10.1093/brain/awx126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.